| 标题 |
Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet 作者:Silverberg JI, Rosmarin D, Bieber T, Chovatiya R, Gooderham M, Gkalpakiotis S, Reich A, Murrell DF, Skibinska J, Sadick N, Blajić I, Tsianakas A, Fernandez-Penas P, Kern JS, Montero-Vílchez T, Popov TA, Kurian A, Sauder MB, Laquer VT, Chaudhry S, Lee ZH, Hannaway M, Yu D, Liu Y, Fanton C, Lu H, Kotzin B, Tagliaferri M, Zalevsky J, Warren RB, REZOLVE-AD Study Investigators 出版日期:2026-08-21 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)